成人隐匿性自身免疫糖尿病患者的肠道菌群与代谢特征:病例对照研究
该年龄性别匹配的病例对照研究纳入30例LADA、31例经典1型糖尿病、30例2型糖尿病和29名健康人,用16S rRNA测序和LC-MS非靶向代谢组学分析。LADA患者肠道菌群结构和代谢物显著不同,产短链脂肪酸菌严重缺乏,菌群结构更接近GAD抗体阳性的1型糖尿病。LADA特征性菌群和代谢物与自身抗体、糖代谢、胰岛功能和炎症因子相关。
要点
- LADA患者肠道菌群结构和代谢物与经典1型、2型糖尿病及健康人均显著不同。
- LADA患者存在产短链脂肪酸菌的严重缺乏,菌群结构更接近GAD抗体阳性1型糖尿病。
- 特征性菌群和代谢物与自身抗体、糖代谢、胰岛功能及炎症因子相关。
核心结论
- LADA患者具有特征性肠道菌群及相关代谢物,与自身抗体、糖代谢、胰岛功能和炎症因子相关,可能参与LADA发病。
研究设计与样本
- 年龄和性别匹配的病例对照研究,纳入30例LADA、31例经典1型糖尿病、30例2型糖尿病和29名健康人。
- 采用16S rRNA基因鉴定肠道菌群,非靶向液相色谱-质谱法测定粪便和血清代谢物。
主要发现
- LADA患者肠道菌群结构和组成及代谢物显著不同,产短链脂肪酸菌严重缺乏。
- LADA患者肠道菌群结构更接近GAD抗体阳性的1型糖尿病患者。
- 鉴定出7个血清代谢物模块和8个粪便代谢物模块在LADA组与其他组间存在差异。
临床怎么用
- LADA患者应关注肠道菌群和代谢物特征,其与自身抗体、糖代谢、胰岛功能及炎症因子相关。
- 未来需纵向研究探索调节肠道菌群及相关代谢物能否改变自身免疫糖尿病自然病程。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 1 and type 2 diabetes are associated with gut dysbiosis. However, the relationship between the gut microbiota and latent autoimmune diabetes in adults (LADA), sharing clinical and metabolic features with classic type 1 and type 2 diabetes, remains unclear. Here, we used a multiomics approach to identify the characteristics of the gut microbiota and metabolic profiles in patients with LADA. RESEARCH DESIGN AND METHODS: This age- and sex-matched case-control study included 30 patients with LADA, 31 patients with classic type 1 diabetes, 30 patients with type 2 diabetes, and 29 healthy individuals. The gut microbiota profiles were identified through the 16S rRNA gene, and fecal and serum metabolites were measured through untargeted liquid chromatography-mass spectrometry. RESULTS: Patients with LADA had a significantly different structure and composition of the gut microbiota and their metabolites as well as a severe deficiency of short-chain fatty acid-producing bacteria. The gut microbiota structure of the patients with LADA was more similar to that of patients with type 1 diabetes who were positive for GAD antibody. We identified seven serum metabolite modules and eight fecal metabolite modules that differed between the LADA group and the other groups. CONCLUSIONS: The characteristic gut microbiota and related metabolites of patients with LADA are associated with autoantibodies, glucose metabolism, islet function, and inflammatory factors, which may contribute to the pathogenesis of LADA. Future longitudinal studies should explore whether modulating the gut microbiota and related metabolites can alter the natural course of autoimmune diabetes in the quest for new therapeutics.
引用
- Fang Y, Zhang C, Shi H, et al. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabetes Care. 2021. PMID: 34620611. doi:10.2337/dc20-2975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。